Athenex Inc (ATNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATNX | AZN | AMGN | GILD | BMY |
| Company | Athenex Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.2200 | 183.86 | 351.80 | 139.68 | 58.22 |
| High | 0.2571 | 186.78 | 353.42 | 139.80 | 58.25 |
| Low | 0.2016 | 183.76 | 348.61 | 136.44 | 57.00 |
| Latest | 0.2031 | 184.07 | 349.77 | 137.34 | 57.00 |
| Change | -0.0620 | +0.47 | +1.97 | +0.13 | -0.48 |
| % Change | -23.39% | +0.26% | +0.57% | +0.09% | -0.84% |
| Volume | 1,880,200 | 2,009,405 | 2,368,600 | 7,362,500 | 10,129,913 |
| 20-Day Average Volume | 532,720 | 1,870,865 | 2,783,295 | 6,927,255 | 15,141,925 |
| Previous Close | 0.2651 | 183.60 | 347.80 | 137.21 | 57.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9093 | 195.88 | 370.21 | 145.03 | 60.17 |
| 20-Day Raw Stochastic | 0.12% | 5.31% | 10.40% | 6.28% | 1.51% |
| 20-Day Relative Strength | 22.55 | 39.13 | 42.99 | 42.46 | 42.61 |
| Weighted Alpha | -90.12 | +24.63 | +17.48 | +25.17 | +4.74 |
| Today's Opinion | 100% Sell | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Previous Opinion | 100% Sell | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -42.15% since 05/17/23 | -4.14% since 03/16/26 | -4.50% since 03/16/26 | -5.42% since 03/16/26 | -4.54% since 03/16/26 |
| Low | 0.2016 on 05/24/23 | 182.62 on 03/20/26 | 344.95 on 03/20/26 | 136.44 on 03/23/26 | 56.91 on 03/20/26 |
| High | 0.3830 on 05/19/23 | 193.96 on 03/17/26 | 368.78 on 03/17/26 | 146.71 on 03/17/26 | 60.81 on 03/17/26 |
| 1-Month | |||||
| %Chg | -83.75% since 04/24/23 | -10.18% since 02/23/26 | -7.81% since 02/23/26 | -8.34% since 02/23/26 | -6.94% since 02/23/26 |
| Low | 0.2016 on 05/24/23 | 182.62 on 03/20/26 | 344.95 on 03/20/26 | 136.44 on 03/23/26 | 56.91 on 03/20/26 |
| High | 1.4699 on 05/03/23 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -92.59% since 02/24/23 | -0.11% since 12/23/25 | +5.51% since 12/23/25 | +9.71% since 12/23/25 | +5.01% since 12/23/25 |
| Low | 0.2016 on 05/24/23 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 2.9800 on 03/06/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -94.12% since 11/23/22 | +21.15% since 09/23/25 | +21.95% since 09/23/25 | +20.05% since 09/23/25 | +26.92% since 09/23/25 |
| Low | 0.2016 on 05/24/23 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 6.0000 on 12/20/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,759 | 284,746,720 | 187,487,840 | 170,335,376 | 117,056,520 |
| Shares Outstanding, K | 8,663 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 102,820,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -103,430,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 8,050,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -34,180,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.36 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -3.38 on 03/20/23 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/30/23 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.63 | 16.01 | 17.31 | 9.45 |